Research Paper Volume 17, Issue 6 pp 1521—1543
Development of a novel transcriptomic measure of aging: Transcriptomic Mortality-risk Age (TraMA)
Figure 2. (A) Regressions of smoker status, cigarette pack years (divided by 10), and forced expiratory volume over one second (FEV1) predicted percentage (divided by ten) on TraMA controlling for age, race, sex/gender, cell type, and batch; points represent regression coefficients and bars represent 95% confidence intervals. (B) Regression of diabetes status on TraMA controlling for age, sex/gender, and cell type; points represent regression coefficients and bars represent 95% confidence intervals. (C) Regressions of inflammatory bowel disease (IBD) status, clinically active IBD, and IBD severity from endoscopy on TraMA controlling for age, sex/gender, and cell type; points represent regression coefficients and bars represent 95% confidence intervals. (D) Regressions of sepsis status, sequential organ failure assessment (SOFA) score, and mortality among sepsis patients on TraMA controlling for age, sex/gender, and cell type; points represent regression coefficients and bars represent 95% confidence intervals.